Related Experiment Videos
Sonographic evaluation of the cervix during ovulation induction
L M Hill1, C B Coulam, S L Kislak
1University of Pittsburgh Health System, PA.
American Journal of Obstetrics and Gynecology
|November 1, 1987
Summary
Ovulation induction with clomiphene citrate and human menopausal gonadotropin can stimulate cervical glands, leading to an anechoic cervical mass visible on ultrasound in about 5% of cases. This finding represents a normal physiological process, not a disease state.
Area of Science:
- Reproductive endocrinology and imaging science.
Background:
- Ovulation induction therapies, including clomiphene citrate and human menopausal gonadotropin, are widely used in fertility treatments.
- These medications can influence various physiological processes within the female reproductive system.
Purpose of the Study:
- To describe a specific sonographic finding associated with ovulation induction.
- To determine the incidence of this finding.
- To differentiate this physiological phenomenon from pathological cervical conditions.
Main Methods:
- Sonographic evaluation of the cervix in patients undergoing ovulation induction.
- Observation and documentation of anechoic cervical masses.
Main Results:
- Clomiphene citrate and human menopausal gonadotropin can stimulate endocervical glands, increasing mucus production.
- An anechoic cervical mass, indicative of significant mucus production, was detected sonographically.
- The incidence of this sonographic finding was approximately 5%.
Conclusions:
- The presence of an anechoic cervical mass during ovulation induction is a physiological response.
- This finding should not be mistaken for cervical pathology.
- Awareness of this sonographic presentation is important for accurate diagnosis in patients undergoing fertility treatments.